SCHEMBL23616686

SCHEMBL23616686

Bc1cc(C(=O)O)cc2ccoc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 3/20 0.44
SLC22A12 Q96S37 3/20 0.44
ACVR1 Q04771 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
DAO P14920 1/20 0.39
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
HSD17B10 Q99714 2/20 0.37
POLB P06746 2/20 0.37
KEAP1 Q14145 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36
MAPK1 P28482 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9903771 0.81 MAPT (0.48) XDHSLC22A12ACVR1MEN1KMT2A
SCHEMBL5987785 0.79 TTR (0.47) XDHSLC22A12ACVR1MEN1KMT2A
SCHEMBL23616996 0.77 KDM4E (0.32) XDHSLC22A12KDM4EMAPTHSD17B10
SCHEMBL10577195 0.76 SLC22A12 (0.59) XDHSLC22A12MEN1KMT2AKEAP1
SCHEMBL19438782 0.75 PTGS2 (0.53) XDHSLC22A12ACVR1KDM4EHSD17B10
SCHEMBL12096314 0.72 KDM4E (0.57) XDHSLC22A12ACVR1MEN1KMT2A
SCHEMBL31056099 0.71 SLC22A12 (0.39) XDHSLC22A12ACVR1KDM4EPOLB
SCHEMBL10576768 0.69 GPR35 (0.46) XDHSLC22A12MEN1KMT2AKDM4E
SCHEMBL23617163 0.69 KDM4E (0.32) XDHSLC22A12KDM4EMAPTHSD17B10
SCHEMBL23617296 0.68 HSP90AB1 (0.46) KDM4EMAPTHSD17B10POLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3687506-B1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS BIOCRYST PHARM INC (US) 2021-07-07 EP disclosed